author-photo

Mi Rim Choi

Amgen

4

Papers

40

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES)

2017 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (14)
Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy

2014 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (14)
Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors

2012 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (12)